NVP-BAW2881
Catalog No. A12693
NVP-BAW2881是有效的选择性VEGFR抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),IC50 为值9 nM,具有抑制慢性和急性皮肤炎症的作用。
Catalog Num | A12693 |
---|---|
M. Wt | 424.1147 |
Formula | C22H15F3N4O2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 861875-60-7 |
Synonyms | BAW2881, BAW-2881, BAW 2881, NVP-BAW-2881, NVP-BAW 2881 |
SMILES | O=C(NC1=CC(C(F)(F)F)=CC=C1)C2=CC=CC3=C2C=CC(OC4=CC=NC(N)=N4)=C3 |
NVP-BAW2881是有效的选择性VEGFR抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),IC50 为值9 nM,具有抑制慢性和急性皮肤炎症的作用。
Targets
Target | Value | |
---|---|---|
TIE-2 | ||
hVEGFR2 | IC50: 9nM | |
C-Raf-1 | IC50: 24nM | |
B-RAFV599E | IC50: 76nM | |
c-Abl | IC50: 99nM | |
mVEGF2 | IC50: 165nM | |
RET | IC50: 410nM | |
hVEGFR3 | IC50: 420nM | |
hVEGFR1 | IC50: 820nM | |
c-KIT | IC50: 2.5μM |
In vitro | DMSO | 76 mg/mL (179.08 mM) | |
Water | Insoluble | ||
Ethanol | 18 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.58 mL | 117.89 mL | 235.79 mL |
0.5 mM | 4.72 mL | 23.58 mL | 47.16 mL |
1 mM | 2.36 mL | 11.79 mL | 23.58 mL |
5 mM | 0.47 mL | 2.36 mL | 4.72 mL |
*The above data is based on the productmolecular weight 424.1147. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.